Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFα blocking agents in rheumatoid arthritis. M Benucci, G Saviola, P Baiardi, E Cammelli, M Manfredi. Clinical rheumatology 27 (1), 91-95
Clarithromycin in rheumatoid arthritis patients not responsive to disease-modifying antirheumatic drugs: an open, uncontrolled pilot study. G Saviola, LA Ali, P Rossini, L Campostrini, A Coppini, M Gori, A Ianaro, ... Clinical and experimental rheumatology 20 (3), 373-37
Correlation between atopy and hypersensitivity reactions during therapy with three different TNF-alpha blocking agents in rheumatoid arthritis. M Benucci, M Manfredi, G Saviola, P Baiardi, P Campi. Clin Exp Rheumatol 27 (2), 333-6
Clodronate and hydroxychloroquine in erosive osteoarthritis: a 24-month open randomized pilot study. G Saviola, L Abdi-Ali, L Campostrini, S Sacco, P Baiardi, M Manfredi, ... Modern rheumatology 22 (2), 256-263
Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study. G Saviola, LA Ali, SS Eddin, A Coppini, F Cavalieri, L Campostrini, ... Rheumatology 46 (6), 994-998
Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life. M Benucci, G Saviola, P Baiardi, M Manfredi. Rheumatology international 31 (11), 1465-1469
Clarithromycin in adult-onset Still’s disease: a study of 6 cases. G Saviola, M Benucci, L Abdi-Ali, P Baiardi, M Manfredi, M Bucci, G Cirino. Rheumatology international 30 (4), 555-560
Early Rheumatoid Arthritis in Italy: study of incidence based on a two-level strategy in a sub-area of Florence (Scandicci-Le Signe). M Benucci, E Cammelli, M Manfredi, G Saviola, P Baiardi, A Mannoni. Rheumatology international 28 (8), 777-78
Effects of monthly intramuscular neridronate in rheumatic patients in chronic treatment with low-dose glucocorticoids. M Benucci, G Saviola, P Baiardi, L Abdi-Ali, MR Povino, S Dolenti, ... Clin Exp Rheumatol 27 (4), 567-57
Clarithromycin in rheumatoid arthritis: the addition to methotrexate and low-dose methylprednisolone induces a significant additive value—a 24-month single-blind pilot study. G Saviola, L Abdi-Ali, L Campostrini, S Sacco, P Baiardi, M Manfredi, ... Rheumatology international 33 (11), 2833-283
